LRRK2 and Parkinson disease: In addition, in the present study, we tested only G2019S mutation; other LRRK2 mutations such as R1441G/C/H also showed elevated LRRK2 kinase activity and may also be tested to determine the contributing role of Mn toxicity in other PD-related mutations.